In Vivo Preclinical Studies
As Part of its In Vivo Preclinical Offer, CALYM Offers in Particular to:
- define the preliminary safety and efficacy profile of drug candidates to optimize the cost-effectiveness of regulatory studies in view of clinical conduct
- establish correlations between genetic analyzes and clinical data
- carry out pharmacology studies
- study activation mechanisms of the immune system
Many lymphoma mouse models are available in our institute: transgenic models, xenografts, PDX ...
New innovative in vivo models closer to the biology can also be developed by our experts.